Presentation and Q&A session scheduled for post-market on Monday, August 15, 2022

BOSTON, Aug. 8, 2022 /PRNewswire/ -- Ginkgo Bioworks (NYSE: DNA), the leading horizontal platform for cell programming, announced today that it plans to host a presentation and Q&A session reviewing business performance for the second quarter ended June 30, 2022, on Monday, August 15, 2022, beginning at 4:30 p.m. ET.

(PRNewsfoto/Ginkgo Bioworks)

The presentation details and webcast link will be available on Ginkgo's investor relations website at, and a replay will be made available.

To ask a question ahead of the presentation, please submit them to @Ginkgo on Twitter (hashtag #GinkgoResults) or by sending an e-mail to

About Ginkgo Bioworks

Ginkgo is building a platform to enable customers to program cells as easily as we can program computers. The company's platform is enabling biotechnology applications across diverse markets, from food and agriculture to industrial chemicals to pharmaceuticals. Ginkgo has also actively supported a number of COVID-19 response efforts, including K-12 pooled testing, vaccine manufacturing optimization and therapeutics discovery. For more information, visit

Ginkgo Bioworks Contacts:




Cision View original content to download multimedia:

SOURCE Ginkgo Bioworks

Copyright 2022 PR Newswire

Ginkgo Bioworks (NYSE:DNA)
Historical Stock Chart
From Aug 2022 to Sep 2022 Click Here for more Ginkgo Bioworks Charts.
Ginkgo Bioworks (NYSE:DNA)
Historical Stock Chart
From Sep 2021 to Sep 2022 Click Here for more Ginkgo Bioworks Charts.